Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
Amgen asks FDA to approve osteoporosis drug
Yahoo
Sat, 12/20/08 - 10:59 am
Tags:
Amgen
,
denosumab
,
osteoporosis
The Pfizer-Amgen Deal Worst-Case Scenario
BNET Pharma
Fri, 12/19/08 - 08:53 am
Tags:
Pfizer
,
Amgen
Biotech Clinical Trials to Watch in 2009
TheStreet.com
Thu, 12/18/08 - 03:43 pm
Tags:
drug trials
,
Alnylam
,
Amgen
,
Amicus Therapeutics
,
Arena Pharmaceuticals
,
Biogen Idec
,
Chelsea Therapeutics
,
Genentech
,
Gilead Sciences
,
Human Genome Sciences
,
InterMune
,
Isis Pharmaceuticals
,
Neurocrine
,
ONYX Pharmaceuticals
,
Orexigen
,
Osiris Therapeutics
,
Poniard
,
Rigel
,
United Therapeutics
,
Synta
Deutsche analyst: Pfizer likely to bid for Amgen
Fierce Biotech
Thu, 12/18/08 - 08:18 am
Tags:
Pfizer
,
Amgen
,
buyouts
Amgen Whistleblower Will Get A Jury Trial
Pharmalot
Wed, 12/17/08 - 08:17 am
Tags:
Amgen
,
whistleblowers
Lilly, Amgen Tell FDA Medicines Should Add Gene Data
Bloomberg
Wed, 12/17/08 - 07:10 am
Tags:
Eli Lilly
,
Amgen
,
FDA
Biotech Stocks with Good Genes
Barrons
Tue, 12/16/08 - 06:14 am
Tags:
Amgen
,
Osiris Therapeutics
,
Cubist Pharmaceuticals
Pages
« first
‹ previous
…
102
103
104
105
106
107
108
109
110
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.